Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis

Cancer Letters

Volumn 240, Issue 2, 2006, Pages 279-288

  Chen, Chung Chi ^a   Hou, Ming Feng ^a   Wang, Jaw Yuan ^a   Chang, Tsai Wang ^b   Lai, Dan Yu ^a   Chen, Yi Fang ^a   Hung, Sung Yu ^c   Lin, Shiu Ru ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c Sung Hua Gene Co Ltd   (Taiwan)

Author keywords

Breast cancer; Membrane array; mRNA marker; Real time Q PCR

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MAMMAGLOBIN; MESSENGER RNA; SCATTER FACTOR RECEPTOR; TUMOR MARKER;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BLOOD CYTOLOGY; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SIZE; CELL DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; KERATINS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 33746239395     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.09.017     Document Type: Article

References (40)

1. Bieche I., Tozlu S., Girault I., and Lidereau R. Identification of a three-gene expression signature of poor-prognosis breast carcinoma. Mol. Cancer 3 1 (2004) 37
2. Smith R.A., Saslow D., Sawyer K.A., Burke W., Costanza M.E., Evans III W.P., et al. American cancer society guidelines for breast cancer screening: update 2003. CA Cancer J. Clin. 53 (2003) 141-169
3. Smith R.A., Cokkinides V., and Eyre H.J. American cancer society guidelines for the early detection of cancer. CA Cancer J. Clin. 53 (2003) 27-43
4. Etzioni R., Urban N., Ramsey S., McIntosh M., Schwartz S., Reid B., et al. The case for early detection. Nat. Rev. Cancer 3 (2003) 243-252
5. Harris R. Variation of benefits and harms of breast cancer screening with age. J. Natl Cancer Inst. Monogr. 22 (1997) 139-143
6. Stathopoulou A., Vlachonikolis I., Mavroudis D., Perraki M., Kouroussis Ch., Apostolaki S., et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J. Clin. Oncol. 20 16 (2002) 3404-3412
7. Weidner N., Carroll P.R., Flax J., Blumenfeld W., and Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143 2 (1993) 401-409
8. Chang Y.S., di Tomaso E., McDonald D.M., Jones R., Jain R.K., and Munn L.L. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc. Natl Acad. Sci. USA 97 26 (2000) 14608-14613
9. Cruz I., Ciudad J., Cruz J.J., Ramos M., Gomez-Alonso A., Adansa J.C., et al. Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples. Am. J. Clin. Pathol. 123 1 (2005) 66-74
10. Fabisiewicz A., Kulik J., Kober P., Brewczynska E., Pienkowski T., and Siedlecki J.A. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay. Acta Biochim. Pol. 51 3 (2004) 747-755
11. Turner R.R., Giuliano A.E., Hoon D.S., Glass E.C., and Krasne D.L. Pathologic examination of sentinel lymph node for breast carcinoma. World J. Surg. 25 (2001) 798-805
12. Stathopoulou A., Gizi A., Perraki M., Apostolaki S., Malamos N., Mavroudis D., et al. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system. Clin. Cancer Res. 9 14 (2003) 5145-5151
13. Y.-F. Chen, J.-Y. Wang, C.-H. Wu, F.-M. Chen, T.-L. Cheng, S.-R. Lin, Detection of circulating cancer cells with K-ras oncogene using membrane array, Cancer Lett. 229 (2005) 115-122.
14. Reinholz M.M., Nibbe A., Jonart L.M., Kitzmann K., Suman V.J., Ingle J.N., et al. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin. Cancer Res. 11 10 (2005) 3722-3732
15. Jotsuka T., Okumura Y., Nakano S., Nitta H., Sato T., Miyachi M., et al. Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer. Surgery 135 4 (2004) 419-426
16. Watson M.A., and Fleming T.P. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 56 (1996) 860-865
17. Leygue E., Snell L., Dotzlaw H., Hole K., Troup S., Hiller-Hitchcock T., et al. Mammaglobin, a potential marker of breast cancer nodal metastasis. J. Pathol. 189 (1999) 28-33
18. Min C.J., Tafra L., and Verbanac K.M. Identification of superior markers for polymerase chain reaction detection of breast cancer metastasis in sentinel lymph nodes. Cancer Res. 58 (1998) 4581-4584
19. Watson M.A., Dintzis S., Darrow C.M., Voss L.E., DiPersio J., Jensen R., and Fleming T.P. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res. 59 (1999) 3028-3031
20. Beviglia L., Matsumoto K., Lin C.S., Ziober B.L., and Kramer R.H. Expression of the c-met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int. J. Cancer 74 (1997) 301-309
21. Camp R.L., Rimm E.B., and Rimm D.L. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer (Phila.) 86 (1999) 2259-2265
22. Ghoussoub R.A., Dillon D.A., D'Aquila T., Rimm E.B., Fearson E.R., and Rimm D.L. Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer (Phila.) 82 (1998) 1513-1518
23. Vernimmen D., Gueders M., Pisvin S., Delvenne P., and Winkler R. Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers. Br. J. Cancer 89 5 (2003) 899-906
24. C.H. Wu, S.R. Lin, J.S. Hsieh, F.M. Chen, C.Y. Lu, F.J. Yu, et al., Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance, Disease Marker, in press.
25. Ring A., Smith I.E., and Dowsett M. Circulating tumour cells in breast cancer. Lancet Oncol. 5 2 (2004) 79-88 (Review)
26. Fabisiewicz A., Kulik J., Kober P., Brewczynska E., Pienkowski T., and Siedlecki J.A. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay. Acta Biochim. Pol. 51 3 (2004) 747-755
27. Krag D.N., Ashikaga T., Moss T.J., Kusminsky R.E., Feldman S., Carp N.Z., et al. Breast cancer cells in the blood: a pilot study. Breast J. 5 (1999) 354-358
28. Vannucchi A.M., Bosi A., Glinz S., Pacini P., Linari S., Saccardi R., et al. Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA. Br. J. Haematol. 103 (1998) 610-617
29. Aerts J., Wynendaele W., Paridaens R., Christiaens M.R., van den Bogaert W., van Oosterom A.T., and Vandekerckhove F. A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. Ann. Oncol. 12 (2001) 39-46
30. Schoenfeld A., Kruger K.H., Gomm J., Sinnett H.D., Gazet J.C., Sacks N., et al. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur. J. Cancer 33 (1997) 854-861
31. Sabbatini R., Federico M., Morselli M., Depenni R., Cagossi K., Luppi M., et al. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J. Clin. Oncol. 18 (2000) 1914-1920
32. Grunewald K., Haun M., Urbanek M., Fiegl M., Muller-Holzner E., Gunsilius E., et al. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab. Invest. 80 (2000) 1071-1077
33. Schoenfeld A., Kruger K.H., Gomm J., Sinnett H.D., Gazet J.C., Sacks N., et al. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur. J. Cancer 33 (1997) 854-861
34. Slade M.J., Smith B.M., Sinnett H.D., Cross N.C., and Coombes R.C. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J. Clin. Oncol. 17 (1999) 870-879
35. An X.Y., Egami H., Hayashi N., Kurusu Y., Yamashita J.I., and Ogawa M. Clinical significance of circulating cancer cells in peripheral blood detected by reverse transcriptase-polymerase chain reaction in patients with breast cancer. Tohoku J. Exp. Med. 193 2 (2001) 153-162
36. Suchy B., Austrup F., Driesel G., Eder C., Kusiak I., Uciechowski P., et al. Detection of mammaglobin expressing cells in blood of breast cancer patients. Cancer Lett. 158 2 (2000) 171-178
37. Lin Y.C., Wu Chou Y.H., Liao I.C., and Cheng A.J. The expression of mammaglobin MRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers. Cancer Lett. 191 1 (2003) 93-99
38. Taback B., Chan A.D., Kuo C.T., Bostick P.J., Wang H.J., Giuliano A.E., and Hoon D.S. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res. 61 24 (2001) 8845-8850
39. Fonseca F.L., Soares H.P., Manhani A.R., Bendit I., Novaes M., Zatta S.M., et al. Peripheral blood c-erbB-2 expression by reverse transcriptase-polymerase chain reaction in breast cancer patients receiving chemotherapy. Clin. Breast Cancer 3 3 (2002) 201-205
40. Jotsuka T., Okumura Y., Nakano S., Nitta H., Sato T., Miyachi M., et al. Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer. Surgery 135 4 (2004) 419-426